Nutritional Therapeutics

Clinical studies show that oral supplementation with the company's patented NTFactor® Lipids significantly reduces fatigue by up to ~43% in aging individuals and those with chronic conditions. The product repairs mitochondrial membranes, restores ATP production, alleviates symptoms of chronic fatigue/fibromyalgia/chemical exposure, improves quality of life in aging populations, and supports cardiovascular health. These results are supported by peer-reviewed research including a recent Nature Cell Science article.

> "MLR therapy with NTFactor® Lipids...repairs mitochondrial membranes, restores ATP production...Clinical studies show that oral NTFactor® supplementation reduces fatigue by up to ~43%..."

The technology was developed in collaboration with Prof. Emeritus Garth Nicolson PhD MD(H), co-author of the Fluid Mosaic Model.

Products are available for both healthcare professionals and consumers worldwide.

No evidence found for prescription drug development or clinical trial pipeline typical of biotech/pharma companies.